The present invention generally relates to magnetic resonance imaging, and more particularly, to devices and methods for marking treatment areas prior to undergoing MRI procedures, and identifying marked areas in MRI images.
Magnetic resonance imaging (MRI) was invented in the 1970s as a means for safely and efficiently locating and identifying subcutaneous or subdermal features, and the field continues to evolve. As is described in U.S. Pat. No. 3,789,832 to Damadian, MRI imaging typically involves applying an oscillating magnetic field to tissue in the presence of a constant magnetic field. After the oscillating magnetic field is removed, spin-lattice relaxation times and spin-spin relaxation times are measured for the various nuclei in the tissue as they return to equilibrium states. By comparing the relaxation times observed in the tissue under examination with known relaxation times for normal tissues and for damaged tissues, the presence and degree of subcutaneous or subdermal damage or other injury may be detected.
The observed relaxation times may be processed and converted into a series of two-dimensional images of the three-dimensional tissue under examination, using a Fourier transform. Like a loaf of bread, the three-dimensional tissue is displayed in a series of two-dimensional images, known as “slices”, which depict the composition of the tissue beneath the surface at selected intervals for the entire width of the tissue. A typical slice may be only a few millimeters wide, thus enabling MRI machines to provide accurate images of subcutaneous or subdermal features with great precision.
However, because a typical MRI slice is so narrow, it is often difficult to pinpoint where a specific portion of injured tissue is located because of the number of slices involved. For example, in areas such as the hands, the wrists or the feet, where compact interactions between bones, muscles and tendons can occupy only a few millimeters of width, it may be difficult to locate injured or damaged tissues and precise areas of pain in limited fields of view. When the MRI is used to assess an area of concern or source of pain based on a surface indication or sensation, such as a bruise, depression or fracture, it is desired to precisely mark the surface of the particular region where the pain or condition has been sensed before commencing MRI imaging, and to be able to identify that particular region in the resulting MRI slice images.
Those of skill in the art have attempted to pinpoint surface areas of concern in MRI imagery with limited success. For example, technicians may mark these regions, which typically exist on fingers, toes, wrists, and the like, in small fields of view by applying makeshift methods and objects such as Vitamin E capsules, cough drops or almonds, which image in respective MRI slices. Although these items can be used to identify points in MRI images, they are often too large to pinpoint precise areas of interest in a finite number of slices, and cannot, by themselves, be readily affixed to a surface area of concern or source of pain.
U.S. Pat. No. 5,427,099 to Adams, which is assigned to the assignee of the present application and incorporated herein by reference in its entirety, describes a marker for MRI imaging that is formed by sealing a pair of plastic sheets to form a cavity. The cavity is filled with a lipid such as mineral oil, vegetable oil or fish oil, and the marker is applied to a patient's body prior to commencing MRI imaging. The markers are approximately two-and-one-half inches by one inch (approximately 63.5 millimeters by 25.4 millimeters) in area, and the plastic sheets are sealed with seams that are approximately one-quarter to three-quarters inches (approximately 6.35 millimeters to 19.05 millimeters) wide. Although the marker disclosed in Adams is flexible and can be affixed to a patient's skin, it is too large to be applied to a specific surface area of concern or source of pain, and cannot be effectively isolated and identified in a minimal number of resulting MRI slices.
Accordingly, it is an object of the present invention to overcome one or more of the above-described drawbacks and/or disadvantages of the prior art.
In accordance with a first aspect, the present invention is directed to a magnetic resonance imaging marker, comprising a body, and a magnetic resonance imaging medium received within the body. The magnetic resonance imaging medium defines a maximum dimension of less than about eight mm such that the magnetic resonance imaging medium cannot visually appear on more than about five consecutive magnetic resonance imaging slices for precisely identifying a point of pain or other specifically identifiable area of interest with the marker on a magnetic resonance image thereof. The marker further includes a mounting member supporting thereon the body and including an adhesive on a surface thereof for adhesively attaching the mounting member and marker on a person's skin at the point of pain or other specifically identifiable area of interest.
Preferably, the mounting member flexibly conforms to the tissue, and the body is sufficiently small, to prevent distortion of pathology. In some embodiments of the invention, the maximum dimension of the magnetic resonance imaging medium is less than or equal to about six mm. In some embodiments of the present invention, the maximum dimension is selected so that the magnetic resonance imaging medium cannot visually appear on more than about three consecutive magnetic resonance imaging slices for precisely identifying the point of pain or other specifically identifiable area of interest with the marker on a magnetic resonance image thereof. In some such embodiments, the maximum dimension is selected so that the magnetic resonance imaging medium cannot visually appear on more than about two consecutive magnetic resonance imaging slices.
In some embodiments of the present invention, the body defines a chamber, and the magnetic resonance imaging medium is received within the chamber. In some such embodiments, the chamber is substantially spherical shaped, and the maximum dimension of the chamber and magnetic resonance imaging medium is the diameter of the chamber. In some embodiments, the magnetic resonance imaging medium is a liquid that is hermetically sealed within the chamber. In some embodiments, the shape of the body is substantially spherical, substantially cubic, substantially rectangular, substantially pyramidal, substantially conic, substantially polyhedronic, or substantially cylindrical. Accordingly, the maximum dimension can be the diameter, width, length or thickness of the magnetic resonance imaging medium. Preferably, the mounting member is a flexible, adhesive-backed substrate.
Some embodiments of the present invention are directed to a device including a plurality of markers that are axially spaced relative to each other on a releasable backing, wherein each mounting member is releasably attached to the releasable backing. In some such embodiments, each mounting member includes a portion that is not adhesively attached to the releasable backing to facilitate manual gripping of such portion and removal of the mounting member from the releasable backing. In some such embodiments, the releasable backing with plural markers mounted thereon is in roll form.
In accordance with another aspect, the present invention is directed to a magnetic resonance imaging marker comprising first means for appearing on a magnetic resonance image, for defining a maximum dimension of less than about eight mm for preventing the magnetic resonance image of the first means from appearing on more than about five consecutive magnetic resonance imaging slices, and for precisely identifying a point of pain or other specifically identifiable area of interest on a magnetic resonance image thereof. The marker further includes second means for supporting thereon the first means and for releasably attaching the first means to a person's skin at the point of pain or other specifically identifiable area of interest.
In some embodiments of the present invention, the first means is a body defining a chamber and a magnetic resonance imaging medium received within the chamber; and the second means is a mounting member supporting the body and including an adhesive thereon for adhesively attaching the mounting member to a person's skin.
In accordance with another aspect, the present invention is directed to a method of magnetic resonance imaging and precisely identifying a point of pain or other specifically identifiable area of interest on a subject, comprising the following steps:
providing a magnetic resonance imaging marker comprising a magnetic resonance imaging medium that defines a maximum dimension of less than about eight mm, and a mounting member including an adhesive on a surface thereof;
adhesively attaching the mounting member and marker on the subject, such as on the subject's tissue or a person's skin, at the point of pain or other specifically identifiable area of interest;
imaging a plurality of consecutive magnetic resonance imaging slices through the marker moving from approximately one side of the marker to approximately another side of the marker, and through subject tissue adjacent to the marker, wherein the total consecutive imaging slices through the marker is not more than about five;
recording the series of consecutive imaging slices; and
precisely identifying the point of pain or other specifically identifiable area of interest in the subject based on the consecutive imaging slices of the marker.
Some embodiments of the present invention include recording the series of consecutive imaging slices such that the resulting series of consecutive imaging slices includes no more than about two consecutive imaging slices of the marker. The method preferably further comprises adhesively attaching the mounting member and marker on the subject substantially without distorting adjacent tissue or pathology, and substantially preventing distortion of tissue or pathology by the marker throughout the imaging procedure.
One advantage of the MRI marker and method of the present invention is that they provide technologists and interpreting physicians with the ability to position a marker precisely on a patient's point of pain or a specifically identifiable point of interest. Yet another advantage of the MRI marker and method of the present invention is that communication between patients, technologists and interpreting physicians can be streamlined as the area of interest can be identified with precision.
These and other advantages of the present invention, and/or of the currently preferred embodiments thereof, will become more readily apparent in view of the following detailed description of the currently preferred embodiments and the accompanying drawings.
In
As is shown in
The material forming the body 12 of the marker 10 is selected such that when the body 12 is filled with the fluid F, the marker 10 is sufficiently firm to maintain its shape throughout an MRI imaging procedure. The exterior surface 16 preferably remains free of depressions, concaves, cavities, pock marks or other deformations to its ordinary shape. The body 12 is preferably formed of materials that are non-metallic to avoid adversely impacting the MRI images, and any portions of the marker that contact a person's skin, preferably are also hypoallergenic to avoid any skin irritation. Suitable materials may include low density polyethylene (LDPE). Such materials need not themselves form a magnetic resonance imaging medium, because the fluid F, and not the materials, is designed to appear in MRI slice images. As may be recognized by those of ordinary skill in the pertinent art based on the teachings herein, the body and MRI imaging medium may be formed of any of numerous different materials that are currently known, or that later become known, for performing the functions of these elements as described herein.
The MRI imaging medium F (which also may be referred to as MRI imaging contrast medium) contained within the interior chamber 14 may be any of numerous different types of MRI imaging mediums that are currently known, or that later become known, for purposes of providing an MRI image that visibly contrasts with the surrounding portions of the image, and that preferably provides a vivid MRI image of the medium. Accordingly, the MRI imaging medium should have a reasonably acceptable signal intensity based on the type of MRI image generated, and preferably has a medium signal intensity, and most preferably has a high signal intensity. Typically, the higher the signal intensity the better. Suitable magnetic resonance imaging mediums for use in the marker 10 include the solution sold by Beekley Corporation under the Radiance® brand. However, any solution, fluid or other MRI imaging medium, such as a suitable variant of the Radiance® fluid, any of the lipids disclosed in U.S. Pat. No. 5,427,099 to Adams, or others, may be used as the MRI imaging medium F. The body 12 should be filled as full of the fluid F or other magnetic resonance imaging medium as is reasonably possible and sealed watertight, and the amount of air or bubbles within the body 12 should be minimized in order to maximize the vividness of the MRI image of the medium F and of the marker 10. Preferably, the maximum width of any bubble within the body 12 is no more than about a third of the maximum internal width d of the body 12.
As described above, the currently preferred embodiments of the marker 10 feature compact geometries which retain their form and shape throughout the MRI imaging process. Preferably, the marker is free of depressions, concavities or other features that would negatively impact or cause a distraction in the resulting MRI image.
As indicated above, a significant advantage of the marker 10 is that it appears in only a limited number of consecutive MRI slices (preferably no more than about five, more preferably no more than about three, and most preferably no more than about two). This feature enables the marker 10 to be precisely applied to an area of concern or source of pain prior to commencing the MRI imaging process, and to mark that area with pinpoint accuracy in the resulting MRI image slices. Because the typical MRI slice is only a few millimeters wide, the marker 10 and, in particular, the maximum internal width d of the body 12, is sized such that the marker 10 appears in only a limited number of MRI slice images as indicated above.
As shown in
The substrate 22 is preferably substantially planar but also flexible, and may be of any shape. Although
When an adhesive 24 is superimposed upon the opposing side of the substrate 22, the marker 10 may be affixed to a selected area of concern or source of pain prior to commencing the MRI imaging process, and the marker 10 appears vividly on the resulting MRI slice images. The substrate 22 and adhesive 24 are preferably thin, such that the fluid-filled body 12 is maintained as close to the person's skin as possible. The adhesive 24 applied to the substrate 22 can be any conventional adhesive typically used in skin-contacting applications. Exemplary adhesives are disclosed in U.S. Pat. Nos. Re. 24,906, 3,389,827, 4,112,213, 4,310,509, 4,323,557, and 4,737,410. Such adhesives preferably transmit moisture vapor at a rate greater than or equal to that of human skin.
As shown in
As is also shown in
As shown in
As may be recognized by those of ordinary skill in the pertinent art based on the teachings herein, numerous changes and modifications may be made to the above-described and other embodiments of the present invention without departing from its scope as defined in the appended claims. For example, the body and imaging medium may be formed of any of numerous different materials that are currently known, or that later become known. The body and/or imaging medium may take any of numerous different configurations and/or shapes. In addition, the mounting portion may take any of numerous different configurations and/or shapes. Similarly, the marker may be used on any of any numerous different subjects for any of numerous different reasons, including person's or animals for medical imaging, or inanimate objects requiring relatively precise MRI imaging analysis. Accordingly, this detailed description of the currently preferred embodiments of the present invention is to be taken in an illustrative, as opposed to a limiting sense.